Summary
Edwards Lifesciences Corporation (EW) announced a key change in its board of directors through a Form 8-K filing. On February 11, 2010, Wesley W. von Schack was appointed as a Class I director, with his term set to expire at the 2010 Annual Meeting of Stockholders. This appointment is significant as Mr. von Schack will also contribute to the company's governance by serving on the Audit and Public Policy Committee. As part of his appointment, Mr. von Schack received an award of 2,331 Restricted Stock Units under the company's Nonemployee Director Stock Incentive Program. This aligns his interests with those of shareholders and signals the board's ongoing commitment to experienced leadership. Investors should note this addition to the board as it may influence future strategic decisions and corporate oversight.
Key Highlights
- 1Appointment of Wesley W. von Schack to the Board of Directors, effective February 11, 2010.
- 2Mr. von Schack's term as a Class I director will expire at the 2010 Annual Meeting of Stockholders.
- 3Mr. von Schack has been appointed to serve on the Audit and Public Policy Committee.
- 4Mr. von Schack was awarded 2,331 Restricted Stock Units upon his appointment.
- 5The award of Restricted Stock Units is part of the Edwards Lifesciences Nonemployee Director Stock Incentive Program.
- 6A press release dated February 12, 2010, announcing the appointment is attached as an exhibit.